The genetic counseling market size is expected to see rapid growth in the next few years. It will grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing adoption of population-scale genetic screening, rising use of digital counseling platforms, expansion of personalized medicine initiatives, growing focus on preventive healthcare, increasing integration of genetic data into clinical decision-making. Major trends in the forecast period include increasing adoption of tele-genetic counseling services, rising demand for carrier screening programs, growing integration of digital genetic risk assessment tools, expansion of preventive and proactive genetic testing, enhanced focus on personalized patient education.
The increasing demand for personalized medicine is expected to drive the growth of the genetic counseling market in the coming years. Personalized medicine involves tailoring medical treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and enhance care. This demand is rising due to advances in genomic technologies, which allow precise identification of genetic variations and the development of tailored treatments. Genetic counseling supports personalized medicine by providing insights based on an individual’s genetic profile, enabling more accurate diagnosis and treatment. It improves patient care by guiding risk assessment, treatment decisions, and preventive strategies, thereby enhancing overall healthcare outcomes. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the FDA approved 26 new personalized medicines in 2023, up from 12 in 2022. Therefore, the growing adoption of personalized medicine is fueling the expansion of the genetic counseling market.
Key companies in the genetic counseling market are focusing on innovative solutions such as consumer-initiated genetic testing platforms, which improve accessibility, personalization, and early detection of health risks. These platforms allow individuals to order genetic tests directly and receive personalized insights without visiting a healthcare provider. For instance, in July 2023, Quest Diagnostics Inc., a US-based diagnostic information services company, launched Genetic Insights, a consumer-initiated genetic testing solution. This platform provides actionable health risk insights, including genetic predispositions to certain conditions, without requiring a physician’s order. It empowers individuals to understand their potential genetic risks for inherited conditions, supported by comprehensive health reports and access to professional genetic counseling. This innovation enhances convenience, promotes proactive health management, and aligns with the growing demand for direct-to-consumer (DTC) genetic testing solutions.
In March 2025, InformedDNA Inc., a US-based genetic counseling provider, acquired Coriell Life Sciences Inc. for an undisclosed amount. This acquisition allows InformedDNA to integrate Coriell’s pharmacogenomic testing and clinical decision support into its DNAimpact platform, expanding the delivery of personalized medication guidance, improving treatment efficacy, and streamlining genetic insights for patients, providers, and payors. Coriell Life Sciences Inc., based in the US, provides pharmacogenomic services and genetic counseling.
Major companies operating in the genetic counseling market are Labcorp Holdings Inc., Quest Diagnostics Incorporated, Natera Inc., Myriad Genetics Inc., MedGenome Diagnostics Private Limited, GeneDx LLC, Color Health Inc., Ambry Genetics Corporation, Genome Medical Inc., Lilac Insights Private Limited, InformedDNA Inc., GeneScreen Counseling Inc., Anderson Diagnostics & Labs Private Limited, MyGeneCounsel LLC, Genetic Counselling India LLP, Genomic Valley Bharat Limited, Tandem Genetics LLC, Metis Genetics LLC, Sanmati Genetic Counseling Center, Invitae Corporation, Centogene N.V.
North America was the largest region in the genetic counseling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic counseling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the genetic counseling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the genetic counseling market by increasing costs of imported genetic testing kits, diagnostic reagents, sequencing instruments, and digital health infrastructure components. Healthcare providers in North America and Europe are most affected due to dependence on imported laboratory technologies, while Asia-Pacific faces higher costs for expanding genetic screening services. These tariffs are increasing service delivery costs and limiting affordability in some regions. However, they are also driving domestic diagnostic manufacturing, local testing capabilities, and investment in regionally developed digital genetic counseling platforms.
The genetic counseling market research report is one of a series of new reports that provides genetic counseling market statistics, including genetic counseling industry global market size, regional shares, competitors with a genetic counseling market share, detailed genetic counseling market segments, market trends and opportunities, and any further data you may need to thrive in the genetic counseling industry. This genetic counseling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Genetic counseling is a process that helps individuals understand and adapt to the medical, psychological, and familial implications of genetic factors in disease. It involves evaluating the risk of inherited conditions, interpreting genetic test results, and guiding informed healthcare decisions. This process supports individuals and families in managing genetic health risks and making well-informed choices regarding their care.
The main types of genetic counseling include preconception counseling, prenatal counseling, carrier screening, and cancer risk assessment. Preconception counseling is a healthcare consultation that helps individuals or couples evaluate and manage medical, genetic, lifestyle, and environmental risks prior to conception to improve pregnancy outcomes. These counseling sessions are typically attended by patients such as individuals with genetic disorders, pregnant women, and family members of affected individuals, and are delivered through various modes, including in-person sessions and telehealth. Genetic counseling is applied across areas such as proactive risk assessment, genetic consultation for intent-to-treat (ITT) patients, prenatal and preconception care, pediatric care, and more, serving end users including hospitals, clinics, diagnostic laboratories, research institutes, and others.
The genetic counseling market includes revenues earned by entities through clinical interpretation, hereditary risk evaluation, wellness genomics, lifestyle-based genomic advice, post-test consultation and related educational resources, data analytics platforms, patient navigation services, outcome monitoring tools, and customized screening protocols. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Genetic Counseling Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses genetic counseling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for genetic counseling? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genetic counseling market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Service Type: Preconception Counseling; Prenatal Counseling; Carrier Screening; Cancer Risk Assessment2) By Patient Type: Individuals With Genetic Disorders; Pregnant Women; Family Members Of Individuals With Genetic Disorders
3) By Delivery Mode: In-Person; Telehealth
4) By Application: Proactive Risk Assessment; Genetic Consultation For Intent-To-Treat Patients (ITT); Prenatal And Preconception Care; Pediatric Care; Other Applications
5) By End-User: Hospitals; Clinics; Diagnostic Laboratories; Research Institutes; Other End-Users
Subsegments:
1) By Preconception Counseling: Family History Evaluation; Genetic Risk Assessment; Carrier Status Analysis2) By Prenatal Counseling: Non-Invasive Prenatal Testing; Amniocentesis Guidance; Ultrasound Risk Evaluation
3) By Carrier Screening: Targeted Mutation Analysis; Panel-Based Screening; Expanded Carrier Testing
4) By Cancer Risk Assessment: Breast Cancer (BRCA1 And BRCA2) Gene Mutation Analysis; Hereditary Cancer Panel Testing; Predictive Genetic Testing
Companies Mentioned: Labcorp Holdings Inc.; Quest Diagnostics Incorporated; Natera Inc.; Myriad Genetics Inc.; MedGenome Diagnostics Private Limited; GeneDx LLC; Color Health Inc.; Ambry Genetics Corporation; Genome Medical Inc.; Lilac Insights Private Limited; InformedDNA Inc.; GeneScreen Counseling Inc.; Anderson Diagnostics & Labs Private Limited; MyGeneCounsel LLC; Genetic Counselling India LLP; Genomic Valley Bharat Limited; Tandem Genetics LLC; Metis Genetics LLC; Sanmati Genetic Counseling Center; Invitae Corporation; Centogene N.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Genetic Counseling market report include:- Labcorp Holdings Inc.
- Quest Diagnostics Incorporated
- Natera Inc.
- Myriad Genetics Inc.
- MedGenome Diagnostics Private Limited
- GeneDx LLC
- Color Health Inc.
- Ambry Genetics Corporation
- Genome Medical Inc.
- Lilac Insights Private Limited
- InformedDNA Inc.
- GeneScreen Counseling Inc.
- Anderson Diagnostics & Labs Private Limited
- MyGeneCounsel LLC
- Genetic Counselling India LLP
- Genomic Valley Bharat Limited
- Tandem Genetics LLC
- Metis Genetics LLC
- Sanmati Genetic Counseling Center
- Invitae Corporation
- Centogene N.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.21 Billion |
| Forecasted Market Value ( USD | $ 3.54 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |


